[REVISION HISTORY]
Italy implements pediatric screening for diabetes and celiac
3 recorded revisions of this situation.
What changed
2026-11-14 00:19 UTC → 2026-11-15 11:33 UTC ·
added
removed
Italy is addressing significant diabetes challenges, with approximately 3.8 million people diagnosed and an estimated 1 million more living with the condition undiagnosed. Most cases involve type 2 diabetes, which is influenced by daily habits such as eating while watching screens. New therapeutic developments include a favorable opinion from the European Medicines Agency for a weekly combination of basal insulin icodec and semaglutide. This formulation aims to improve glycemic control and reduce treatment complexity. Following the enactment of Law 130 of 2023, Italy has established a national pediatric screening program for type 1 diabetes and celiac disease. During a World Diabetes Day event at the Chamber of Deputies, officials and medical experts noted that this legislation makes Italy a “global pioneer in population-wide pediatric screening.” Health Minister Orazio Schillaci and Deputy Speaker Giorgio Mulè have highlighted the law as a global model for preventive medicine. The program aims for early diagnosis to prevent ketoacidosis, a severe complication often seen in preschool-aged children. By identifying children with specific antibodies, medical professionals can provide close medical and psychological follow-up, offering a window of several years to manage the condition before full onset. Pilot projects, such as the PreSchool D1Ce Screen, are being developed to target children aged 3 to 5 using a non-invasive dried blood spot (DBS) method. Implementation is expected to expand across regions as implementing decrees are finalized, with a focus During recent discussions on ensuring uniform access to World Diabetes Day, medical devices and specialized care nationwide. Experts emphasize professionals, including Raffaella Buzzetti of the Italian Society of Diabetology, emphasized that continued investment while the law is necessary to transition a major achievement, the next steps require structuring detailed monitoring paths. Experts stress that moving from exploratory pilot phases to full national implementation. implementation is essential to ensure uniform treatment across all Italian regions and avoid healthcare fragmentation.
Versions
- 2026-11-15 11:33 UTC Italy implements pediatric screening for diabetes and celiac
- 2026-11-14 00:19 UTC Italy implements pediatric screening for diabetes and celiac
- 2026-11-13 18:26 UTC Italy implements pediatric screening for diabetes and celiac
- 2026-11-13 17:17 UTC Diabetes management and screening in Italy
Select a version to see what changed compared to the one before it.